Computed Tomography in Oncology
Oncological imaging using CT imaging is daily business for nearly all radiology departments. From screening to staging to treatment guidance to follow-up imaging, CT can be present in every step of the process. Our range of CT systems provide features across the product line up from volumetric CT to the world’s first Ultra High Resolution CT to ensure for every oncological pathway the best image quality.
The Celesteion PET-CT is designed with patients in mind. With the industry’s largest bore of 90 cm (CT) and 88 cm (PET), a true scan field of view at 70 cm (CT and PET) and Time-of-Flight technology, Celesteion can enable facilities to improve care in the field of metabolic lesion assessment and effectiveness of treatment plans.
Ultra-High Resolution CT
SURESubtraction iodine mapping
SURESubtraction can create iodine maps to enable the assessment of the distribution of contrast media within the body to visualize local perfusion. These maps can be applied to assess the local vascularization and therefore differentiate solid from cystic lesions and evaluating treatment effects in the field of Oncology.
Whole Organ Perfusion
“ SURESubtraction Iodine Mapping increases the diagnostic information available for any routine multiphase body protocol by extracting the iodine enhancement on each phase. The iodine signal is displayed in color blood flow maps to help assess local vascularization. These maps can be widely applied and aid, for example, in differentiating solid from cystic lesions, evaluating treatment effects, distinguishing hypo-from hypervascular lesions, and establishing organ ischemia.”
Prof. Mathias Prokop
Professor and Chairman of Radiology and Nuclear Medicine,
Radboud University Medical Center, Nijmegen, the Netherlands